BAX - Baxter International Inc.
| Previous Close | 67.54 |
| Open | 67.40 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 2900 |
| Day's Range | 67.40 - 68.41 |
| 52 Week Range | 61.05 - 78.38 |
| Volume | 4,253,085 |
| Avg. Volume | 4,457,678 |
| Market Cap | 36.324B |
| Beta (3Y Monthly) | 1.05 |
| PE Ratio (TTM) | 31.27 |
| EPS (TTM) | 2.18 |
| Earnings Date | Jan 31, 2019 |
| Forward Dividend & Yield | 0.76 (1.13%) |
| Ex-Dividend Date | 2018-11-30 |
| 1y Target Est | 75.29 |
- Zacks•2 days ago
Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings?
Intuitive Surgical's (ISRG) top line in the fourth quarter of 2018 is likely to benefit from solid grow that the Instruments and Accessories segment.
- Markit•2 days ago
See what the IHS Markit Score report has to say about Baxter International Inc.
# Baxter International Inc ### NYSE:BAX View full report here! ## Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is extremely low for BAX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BAX. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $12.24 billion over the last one-month into ETFs that hold BAX are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap | Negative The current level displays a negative indicator. BAX credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•2 days ago
Varian Medical (VAR) to Report Q1 Earnings: What's in Store?
Strong overseas presence and product launches are likely to aid Varian Medical's (VAR) fiscal first-quarter results.
- Markit•8 days ago
See what the IHS Markit Score report has to say about Baxter International Inc.
# Baxter International Inc ### NYSE:BAX View full report here! ## Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is extremely low for BAX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BAX. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, growth of ETFs holding BAX is favorable, with net inflows of $22.94 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap | Negative The current level displays a negative indicator. BAX credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•9 days ago
Stock Market News For Jan 8, 2019
Wall Street rallied for the second consecutive day on Monday after resumption of trade related negotiations between the United States and China
- Zacks•9 days ago
Baxter's PD Solution to Treat Patients, Prospects Bright
Baxter's (BAX) kidney care portfolio likely to favor the company as kidney care demand shoots up in the United States.
- Business Wire•10 days ago
Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System
Baxter International Inc. (BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.S. clinical trial for the company’s on-demand peritoneal dialysis (PD) solution generation system. The innovative system is designed to improve the patient experience by making PD solutions in small batches in the patient’s home.
- Market Realist•13 days ago
GE’s Healthcare Unit Spin-Off to Enhance Shareholder Wealth
Will Restructuring Initiatives Put GE Back on Growth Trajectory? As part of its June 2018 major restructuring plan, General Electric (GE) intends to spin off the Healthcare segment and turn it into a standalone entity. The move is believed to be another step by newly appointed CEO Larry Culp to optimize the company’s business and strengthen its liquidity position.
- Zacks•14 days ago
Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?
Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Benzinga•15 days ago
Morgan Stanley Finds A Few Reasons To Double Upgrade Baxter
Shares of Baxter International Inc (NYSE: BAX ) are trading at a valuation that implies low growth, but Morgan Stanley sees three catalysts ahead that will likely result in top-and-bottom line acceleration ...
- Simply Wall St.•15 days ago
Read This Before Buying Baxter International Inc. (NYSE:BAX) For Its Dividend
Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. Historically, Baxter International Inc. (NYSE:BAX) has Read More...
GuruFocus.com•17 days ago6 Undervalued Stocks Growing Earnings
The earnings per share of Ross Stores Inc. (ROST) have grown 15% annually over the last five years. According to the DCF calculator, the stock is undervalued and is trading with a 33 % margin of safety at $82.61 per share. The price-earnings ratio is 19.
- Zacks•24 days ago
Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III
Mallinckrodt (MNK) and partner NPXe Limited enrol the first patient in the phase III study on xenon gas for inhalation (XENEX) for Post Cardiac Arrest Syndrome (PCAS).
- Business Wire•27 days ago
Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for Investors
Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its fourth quarter 2018 financial results on Thursday, January 31, 2019, at 7:30 a.m. Central Time. The Conference ID is 5056779.
- Insider Monkey•28 days ago
4 Stocks Respected Activist Investor Jeffrey Smith Bought in Q3 (and 1 He Dumped)
Jeffrey Smith‘s Starboard Value is one of the most followed and well respected activist hedge funds out there, consistently spurring positive operational changes at companies that it invests in and driving shares higher, which is why the fund likes to use the term “operational activist” to describe itself. Perrigo Company plc (NYSE:PRGO) Rockwell Collins, Inc. […]
- GlobeNewswire•28 days ago
New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Dec. 20, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
GuruFocus.com•29 days agoCredit Suisse Initiates Coverage of Large Health Care Stocks
The Swiss firm says Abbott Labs, Boston Scientific, Medtronic, Stryker, Baxter International and Edwards Lifesciences will outperform, while Zimmer Biomet will underperform
- Zacks•29 days ago
Stock Market News For Dec 19, 2018
U.S. stocks closed mostly higher on Tuesday after a volatile session, reversing stiff decline in previous two trading days
- Business Wire•last month
Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures
Baxter International Inc. (BAX), a global leader in advancing surgical innovation, today announced the introduction of the Disposable Curved Applicator, which enhances the delivery experience of its Floseal Hemostatic Matrix product line for procedures in the otolaryngology, head and neck surgical specialty (often referred to as ENT). With an atraumatic design to help minimize tissue damage during use and a 10cm rigid stainless steel cannula, the Disposable Curved Applicator allows for improved access to the bleeding site and controlled delivery of Floseal. ENT procedures most relevant for this new applicator include addressing intraoperative bleeding during skull base surgery, functional endoscopic sinus surgeries, septoplasties (correction of a deviated septum) and for the control of operative and post-operative bleeding (epistaxis) during nasal and sinus surgery.
- Simply Wall St.•last month
At US$65.70, Is It Time To Put Baxter International Inc. (NYSE:BAX) On Your Watch List?
Let's talk about the popular Baxter International Inc. (NYSE:BAX). The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, Read More...
- Zacks•last month
Here's Why You Should Hold Baxter International (BAX) Now
Baxter's (BAX) recent string of developments boost the stock while segmental softness is a concern.
Markit•last monthSee what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
Market Realist•last monthHow Medtronic’s Cardiac and Vascular Group Performed
Medtronic’s (MDT) Cardiac & Vascular Group generated revenues of $2.9 billion in the second quarter of fiscal 2019 compared to $2.8 billion in the second quarter of fiscal 2018, reflecting ~3% YoY growth.
Market Realist•last monthWill GE’s Healthcare Unit Spin-Off Increase Shareholder Wealth?
Why Has General Electric Stock Struggled in 2018? The Healthcare segment is the fourth-largest contributor to General Electric’s total revenues. As part of the company’s major restructuring plan in June, General Electric intends to spin off the segment and turn it into a standalone entity.
